This page provides a single source of information and resources regarding the impact of COVID-19 on diabetes care delivery.
Intermed
Intermed are business as ‘usual’ – from home. See also their letter to patients (linked under Patient Information on the right).
MediRay
MediRay is continuing to provide full service to their FreeStyle Libre customers.
All inquiries to free phone 0800 106 100 or www.freestylelibre.co.nz
George E Bongiovanni
Medi’Ray NZ Ltd
0800 106 100
Novo Nordisk
During the global coronavirus outbreak, Novo Nordisk’s key priority is to safeguard the continued supply of our medicines to patients. The situation is continually evolving, but currently we are not experiencing any supply constraints. We are well prepared for situations like this and have an inventory policy that guarantees long-term supply. This is important since our medicines are needed every day by patients all over the world.
We would like to reassure you that Novo Nordisk is monitoring demand for our medicines in Australia and New Zealand and working with wholesalers, distributors, pharmacies and other key stakeholders to ensure patients can access their medicines where and when they need them.
NZMS
As an essential medical supplier, NZMS will continue our operations throughout the Level 4 Alert. This means that we will continue processing orders, and deliveries will continue as normal. As per the government guidelines, all non-essential staff have moved to remote working and measures have been put in place to ensure continued operations in our warehouse. Regardless, we all still remain available as we always have for any enquiries and technical support.
Sanofi
“Sanofi remains fully committed to ensuring continuity of supply for all our products. Across the globe, our manufacturing sites all remain operational.
The COVID-19 situation is evolving quickly, in Australia and New Zealand and our local team is continuing to work across our global supply network, as well as with local wholesalers and customers to support continuity of supply. We continue to work closely with Medsafe, PHARMAC, government and other bodies as required.
At this stage we do not have any immediate COVID-19 related shortages to report for prescription medicines or vaccines, however, we are continuing to closely monitor the local situation.“
